Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -128.17%-3.61M | ---- | 282.80%29.83M | ---- | 79.61%12.8M | ---- | -37.07%7.79M | ---- | --7.13M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -812.67%-721.83K | ---- | -1,975.79%-804.48K | ---- | -2,247.54%-79.09K | ---- | -112.72%-38.76K | ---- | ---3.37K |
| Investment loss (gain) | ---- | -9.40%-2.43M | ---- | -290.75%-9.2M | ---- | -233.53%-2.22M | ---- | -87.04%4.82M | ---- | --1.66M |
| Impairment and provisions: | ---- | -114.05%-1.02M | ---- | 1,859.90%10.88M | ---- | 1,132.74%7.29M | ---- | 118.42%555.34K | ---- | --591.6K |
| -Other impairments and provisions | ---- | -3.31%-531.36K | ---- | -188.75%-492.84K | ---- | -186.94%-514.32K | ---- | 118.42%555.34K | ---- | --591.6K |
| Revaluation surplus: | ---- | -872.24%-5.67M | ---- | 6.46%-19.25M | ---- | 95.97%-582.84K | ---- | -272.12%-20.58M | ---- | ---14.47M |
| Asset sale loss (gain): | ---- | 1,070.54%397.83K | ---- | -65.96%40.34K | ---- | 55.65%33.99K | ---- | 15.76%118.52K | ---- | --21.84K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 1,070.54%397.83K | ---- | -65.96%40.34K | ---- | 55.65%33.99K | ---- | 15.76%118.52K | ---- | --21.84K |
| Depreciation and amortization: | ---- | -17.37%14.67M | ---- | 1.54%34.28M | ---- | 4.98%17.75M | ---- | 77.88%33.76M | ---- | --16.91M |
| -Amortization of intangible assets | ---- | 0.00%85.89K | ---- | --171.77K | ---- | --85.89K | ---- | ---- | ---- | ---- |
| Financial expense | ---- | -88.44%290.82K | ---- | -44.69%3.17M | ---- | -8.88%2.52M | ---- | -17.97%5.74M | ---- | --2.76M |
| Exchange Loss (gain) | ---- | -2,072.60%-809.13K | ---- | 201.95%308.59K | ---- | 109.59%41.02K | ---- | 93.72%-302.68K | ---- | ---427.77K |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 349.88%408.9M | ---- | -457.63%-356.98M | ---- | -1,071.31%-163.64M | ---- | -671,734.70%-64.02M | ---- | ---13.97M |
| Accounts receivable (increase)decrease | ---- | 64.57%-407.78M | ---- | 142.03%174.22M | ---- | -108.41%-1.15B | ---- | -1.46%-414.52M | ---- | ---552.32M |
| Accounts payable increase (decrease) | ---- | -124.29%-874.41M | ---- | 310.12%2.47B | ---- | 498.69%3.6B | ---- | -152.13%-1.17B | ---- | ---903.08M |
| Special items of business | ---- | -47.54%2.35M | ---- | 232.25%13.57M | ---- | 150.15%4.47M | ---- | 607.45%4.08M | ---- | --1.79M |
| Adjustment items of business operations | -64.13%874.25M | -137.54%-872.23M | -291.00%-3.25B | 244.00%2.33B | 206.84%2.44B | 259.66%2.32B | 194.44%1.7B | -184.24%-1.62B | -572.65%-2.28B | -142.97%-1.46B |
| Net cash from operations | -64.13%874.25M | -137.37%-869.89M | -291.00%-3.25B | 245.20%2.35B | 206.84%2.44B | 260.16%2.33B | 194.44%1.7B | -184.00%-1.62B | -572.65%-2.28B | -142.91%-1.45B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -51.08%4.79M | -63.31%3.09M | -69.68%2.35M | -47.49%9.11M | 9.60%9.8M | 17.58%8.43M | 285.46%7.76M | 1.87%17.35M | -4.63%8.94M | 3,313.30%7.17M |
| Sale of fixed assets | 132.39%27.1K | 4,538.51%427.27K | 1,542.42%27.1K | -58.14%54.2K | -98.54%11.66K | -58.88%9.21K | -99.77%1.65K | 2,088.91%129.49K | 4,023.69%797.94K | 4,962.92%22.4K |
| Purchase of fixed assets | 82.45%-1.57M | 73.88%-2.29M | 42.38%-1.42M | 42.56%-16.37M | 59.30%-8.95M | 56.63%-8.77M | 24.81%-2.46M | 58.93%-28.49M | 52.34%-22M | -45.78%-20.22M |
| Recovery of cash from investments | 21.20%16.28B | 39.98%10.2B | 139.63%4.7B | 17.63%18.53B | 17.02%13.43B | 2.98%7.29B | 983.88%1.96B | 161.02%15.75B | 132.08%11.48B | 137.70%7.07B |
| Cash on investment | -20.15%-16.35B | -37.31%-10.27B | -105.08%-4.69B | -18.34%-18.48B | -17.24%-13.61B | -3.42%-7.48B | -861.66%-2.29B | -167.75%-15.62B | -136.37%-11.61B | -140.47%-7.23B |
| Other items in the investment business | ---527.59 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 60.33%-70.7M | 65.12%-66.72M | 103.87%12.37M | -69.00%37.79M | -24.06%-178.23M | -14.37%-191.26M | -457.45%-319.56M | -18.15%121.9M | -5,195.26%-143.66M | -284.63%-167.24M |
| Net cash before financing | -64.42%803.55M | -143.84%-936.61M | -334.34%-3.23B | 259.56%2.39B | 193.16%2.26B | 231.83%2.14B | 174.31%1.38B | -172.09%-1.5B | -605.26%-2.42B | -148.47%-1.62B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 2,114.43%110.72M | 2,114.43%110.72M | 1,934.66%101.73M | -16.92%66.06M | -93.71%5M | -89.95%5M | --5M | 59.02%79.51M | --79.51M | --49.74M |
| Refund | -69.24%-139.72M | -49.56%-114.72M | -997.32%-76.73M | -155.92%-147.78M | -62.67%-82.56M | -448.47%-76.71M | 0.00%-6.99M | 25.94%-57.75M | -139.51%-50.75M | -4.87%-13.99M |
| Dividends paid - financing | -62.39%-9.7M | ---- | 60.08%-263.4K | 80.92%-6.45M | 82.19%-5.97M | 93.57%-2.02M | 97.88%-659.85K | -465.31%-33.83M | -619.39%-33.52M | -898.77%-31.46M |
| Other items of the financing business | 92.31%-5.1M | 78.60%-9.54M | 59.66%-5.08M | -3,125.59%-68.97M | -1,088.40%-66.38M | -303.89%-44.59M | -224.89%-12.59M | 111.17%2.28M | 295.37%6.72M | -61.24%21.87M |
| Net cash from financing operations | 70.78%-43.8M | 88.56%-13.54M | 228.97%19.66M | -1,505.34%-157.14M | -7,780.15%-149.91M | -552.30%-118.32M | 45.76%-15.24M | -108.17%-9.79M | -98.65%1.95M | -34.50%26.16M |
| Effect of rate | 101.07%56.52K | -44.12%526.92K | -354.47%-559.7K | -554.67%-4.71M | -215.65%-5.27M | -81.51%942.99K | 106.45%219.95K | -93.69%1.04M | -75.54%4.56M | -47.48%5.1M |
| Net Cash | -63.97%759.75M | -147.08%-950.15M | -335.52%-3.21B | 248.08%2.23B | 187.05%2.11B | 226.57%2.02B | 172.39%1.36B | -168.60%-1.51B | -487.77%-2.42B | -147.13%-1.59B |
| Begining period cash | 44.14%6.94B | 46.21%7.04B | 46.21%7.04B | -23.81%4.81B | -23.81%4.81B | -23.81%4.81B | -24.20%4.81B | 53.83%6.32B | 53.83%6.32B | 53.83%6.32B |
| Cash at the end | 11.28%7.7B | -10.90%6.09B | -38.12%3.82B | 46.21%7.04B | 77.41%6.92B | 44.52%6.83B | 38.49%6.18B | -23.81%4.81B | -17.92%3.9B | -36.97%4.73B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.